Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance upgrade on Thursday 4th of May 2017 from 8.00am to 9.00am (BST).

During this time our websites will be offline temporarily. If you have any questions please use the feedback button on this page. We apologise for any inconvenience this might cause and thank you for your patience.

Supplementation with n-3, n-6, n-9 fatty acids in an insulin-resistance animal model: Does it improve VLDL quality?


Insulin-resistance (IR), of increased cardiovascular risk, is characterized by the production of altered VLDL with greater atherogenicity. Dietary fatty acids influence on the type of circulating VLDL. But, it is not clear how dietary fatty acids impact on VLDL characteristics in IR. Aim: to evaluate the effects of n-3, n-6 and n-9 fatty acid supplementation on preventing atherogenic alterations in VLDL, in a diet-induced IR rat model. Male Wistar rats (180-200g) were fed with: standard diet (control, n=8) and with sucrose rich diet (30% sucrose in water/12 weeks, SRD; n=24). Simultaneously, SRD was subdivided in SRD-C (standard diet), and three other groups supplemented (15% w/w) with: fish oil (SRD-n3), sunflower oil (SRD-n6) and high oleic sunflower oil (SRD-n9). Lipid profile, free fatty acids, glucose, and insulin were measured. Isolated VLDL (d<1.006 g/ml) was characterized by chemical composition and size (size exclusion-HPLC). In comparison to SRD-C: SRD-n3 showed an improved lipoprotein profile (p<0.01), with lower insulin and HOMA-IR (p<0.05). SRD-n6 showed increased HDL-cholesterol and lower insulin. SRD-n9 did not exhibit differences in lipid and IR profile, and even favored weight gain and visceral fat. Only SRD-n3 prevented the alterations in VLDL-TG% (54.2±4.4% vs 68.6±8.2, p<0.05) and showed lower large VLDL-% (22.5[19.7-35.6] vs 49.1[15.5-82.0], p<0.05), while SRD-n6 and SRD-n9 did not show effects. Conclusion: In IR, while n-3 PUFA showed expected favorable effects, supplementation with n-6 PUFA and n-9 MUFA did not prevent atherogenic alterations of VLDL. Thus, the recommendations of supplementation with these fatty acids in general diet should be revised.

Back to tab navigation
Please wait while Download options loads

Publication details

The article was received on 15 Feb 2017, accepted on 19 Apr 2017 and first published on 20 Apr 2017

Article type: Paper
DOI: 10.1039/C7FO00252A
Citation: Food Funct., 2017, Accepted Manuscript
  •   Request permissions

    Supplementation with n-3, n-6, n-9 fatty acids in an insulin-resistance animal model: Does it improve VLDL quality?

    D. M. Lucero, C. Olano, M. Bursztyn, C. Morales, A. Stranges, S. M. Friedman, E. V. Macri, L. Schreier and V. Zago, Food Funct., 2017, Accepted Manuscript , DOI: 10.1039/C7FO00252A

Search articles by author